garsorasib (D-1553 )

Garsorasib (D-1553 ) is a potent and selective oral KRASG12C inhibitor with antitumor activity. It has the potential to treat KRAS G12C-mutated non-small cell lung cancer (NSCLC).
Supplier Selleck Chemicals
Product # E1578
Sku # E1578-5mg
Pricing 5mg, $397.00
Feedback